Journal Mobile Options
Table of Contents
Vol. 21, No. 2, 2008
Issue release date: March 2008
Skin Pharmacol Physiol 2008;21:106–110

Investigation of the Anti-Inflammatory Potential of Aloe vera Gel (97.5%) in the Ultraviolet Erythema Test

Reuter J. · Jocher A. · Stump J. · Grossjohann B. · Franke G. · Schempp C.M.
aDepartment of Dermatology, University Medical Center Freiburg, Freiburg, and bRiemser Arzneimittel AG, Insel-Riems, Germany

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background:Aloe vera is a natural product that is frequently used in soothing skin care products such as aftersun lotions. In the present study we aimed to explore the anti-inflammatory potential of a highly concentrated A. vera gel in the UV erythema test in vivo. Methods: 40 volunteers with skin types II and III were included in the randomized, double-blind, placebo-controlled, phase III monocenter study. Test areas on the back were irradiated with the 1.5-fold minimal erythema dose of UVB. Subsequently, the test areas were treated occlusively on 2 subsequent days with A. vera gel (97.5%), the positive controls (0.25% prednicarbate, 1% hydrocortisone in placebo gel and 1% hydrocortisone cream) and a placebo gel. Erythema values were determined photometrically after 24 and 48 h. Results:A. vera gel (97.5%) significantly reduced UV-induced erythema after 48 h, being superior to 1% hydrocortisone in placebo gel. In contrast, 1% hydrocortisone in cream was more efficient than A. vera gel. Conclusions: In this study after 48 h the A. vera gel (97.5%) displayed some anti-inflammatory effects superior to those of 1% hydrocortisone in placebo gel. The A. vera gel tested here might be useful in the topical treatment of inflammatory skin conditions such as UV-induced erythema.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Boudreau MD, Beland FA: An evaluation of the biological and toxicological properties of Aloe barbadensis (Miller), Aloe vera. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2006;24:103–154.
  2. Klein AD, Penneys NS: Aloe vera. J Am Acad Dermatol 1988;18:714–720.
  3. Davis RH, Agnew PS, Shapiro E: Antiarthritic activity of anthraquinones found in aloe for podiatric medicine. J Am Podiatr Med Assoc 1986;76:61–66.
  4. Pecere T, Gazzola MV, Mucignat C, Parolin C, Vecchia FD, Cavaggioni A, Basso C, Diaspro A, Salvato B, Carli M, Palu G: Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res 2000;60:2800–2804.
  5. Yongchaiyudha S, Rungpitarangsi V, Bunyapraphatsara N, Chokechaijaroenporn O: Antidiabetic activity of Aloe vera L. juice. I. Clinical trial in new cases of diabetes mellitus. Phytomedicine 1996;3:241–243.

    External Resources

  6. Avijgan M: Phytotherapy: an alternative treatment for non-healing ulcers. J Wound Care 2004;13:157–158.
  7. Somboonwong J, Thanamittramanee S, Jariyapongskul A, Patumaj S: Therapeutic effects of Aloe vera on cutaneous microcirculation and wound healing in second degree burn model in rats. J Med Assoc Thai 2000;83:417–425.
  8. Vázquez B, Avila G, Segura D, Escalante B: Antiinflammatory activity of extracts of Aloe vera gel. J Ethnopharmacol 1996;55:69–75.
  9. Rees TD: Oral ulcers remedy gets FDA clearance. J Am Dent Assoc 1994;125:1308–1310.

    External Resources

  10. Byeon SW, Pelley RP, Ullrich SE, Waller TA, Bucana CD, Strickland FM: Aloebarbadensis extracts reduce the production of interleukin-10 after exposure to ultraviolet radiation. J Invest Dermatol 1998;110:811–817.
  11. Seyger MM, van de Kerkhof PC, van Vlijmen-Willems IM, de Bakker ES, Zwiers F, de Jong EM: The efficacy of a new topical treatment for psoriasis: Mirak. J Eur Acad Dermatol Venereol 1998;11:13–18.
  12. Roesler J, Steinmuller C, Kiderlen A, Emmendorffer A, Wagner H, Lohmann-Matthes ML: Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to mice mediates protection against systemic infections with Listeria monocytogenes and Candida albicans. Int J Immunopharmacol 1991;13:27–37.
  13. Vogler BK, Ernst E: Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract 1999;49:823–828.
  14. Reynolds T, Dweck AC: Aloe vera leaf gel: a review update. J Ethnopharmacol 1999;68:3–37.
  15. Capasso F, Borrelli F, Di Carlo G, Izzo AA, Pinto L, Mascolo N, Castaldo S, Longo R: Aloe and its therapeutic use. Phytother Res 1998;12:124–127.

    External Resources

  16. Juhlin L, Shroot B: Effect of drugs on the early and late phase UV erythema. Acta Derm Venereol 1992;72:22–23.

    External Resources

  17. Takiwaki H, Shirai S, Kohno H, Soh H, Arase S: The degrees of UVB-induced erythema and pigmentation correlate linearly and are reduced in a parallel manner by topical anti-inflammatory agents. J Invest Dermatol 1994;103:642–646.
  18. Hughes-Formella BJ, Bohnsack K, Rippke F, Benner G, Rudolph M, Tausch I, Gassmueller J: Anti-inflammatory effect of hamamelis lotion in a UVB erythema test. Dermatology 1998;196:316–322.
  19. Jocher A, Kessler S, Hornstein S, Schulte Monting J, Schempp CM: The UV erythema test as a model to investigate the anti-inflammatory potency of topical preparations – reevaluation and optimization of the method. Skin Pharmacol Physiol 2005;18:234–240.
  20. Fitzpatrick T: The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988;124:869–871.
  21. Schempp CM, Muller K, Schulte-Monting J, Schopf E, Simon JC: Salt water bathing prior to UV-B irradiation leads to a decrease of the minimal erythema dose and an increased erythema index without affecting skin pigmentation. Photochem Photobiol 1999;69:341–344.
  22. Krutmann J, Hönigsmann H: Handbuch der dermatologischen Phototherapie und Photodiagnostik. Berlin, Springer, 1997, pp 359–367.
  23. Hughes-Formella BJ, Filbry A, Gassmueller J, Rippke F: Anti-inflammatory efficacy of topical preparations with 10% hamamelis destillate in a UVB erythema test. Skin Pharmacol Appl Skin Physiol 2002;15:125–132.
  24. Rhodes LE, Friedman PS: A comparison of the ultraviolet B-induced erythemal response of back and buttock skin. Photoderm Photoimmunol Photomed 1992;9:48–51.
  25. Hutter JA, Salman M, Stavinoha WB, Satsangi N, Williams RF, Streeper RT, Weintraub ST: Antiinflammatory C-glucosyl chromone from Aloe barbadensis. J Nat Prod 1996;59:541–543.
  26. Davis RH, Donato JJ, Hartman GM, Haas RC: Anti-inflammatory and wound healing activity of a growth substance in Aloe vera. J Am Podiatr Med Assoc 1994;84:77–81.
  27. Crowell J, Hilsenbeck S, Penneys N: Aloe vera does not affect cutaneous erythema and blood flow following ultraviolet B exposure. Photodermatology 1989;6:237–239.
  28. Morrow DM, Rapaport MJ, Strick RA: Hypersensitivity to aloe. Arch Dermatol 1980;116:1064–1065.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50